BioLineRx Ltd. (BLRX)
BioLineRx Statistics
Share Statistics
BioLineRx has 3.72M shares outstanding. The number of shares has increased by 74.04% in one year.
| 3.72M |
| 74.04% |
| 34.18% |
| 0% |
| n/a |
| 770 |
| 0.12% |
Short Selling Information
The latest short interest is 181.45K, so 4.88% of the outstanding shares have been sold short.
| 181.45K |
| 4.88% |
| 4.89% |
| 13.47 |
Valuation Ratios
The PE ratio is -74.15 and the forward PE ratio is -17.96. BioLineRx's PEG ratio is 0.84.
| -74.15 |
| -17.96 |
| 23.63 |
| 1 |
| 50.79 |
| -15.56 |
| 0.84 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BioLineRx.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 1.12.
| 1.76 |
| 1.56 |
| 1.12 |
| 3.84 |
| -0.34 |
| -2.25 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $1,033,571.43 |
| $-329,321.43 |
| 28 |
| 0.74 |
| 2.95 |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -81.41% in the last 52 weeks. The beta is 0.86, so BioLineRx's price volatility has been higher than the market average.
| 0.86 |
| -81.41% |
| 3.29 |
| 10.61 |
| 69.71 |
| 625,819 |
Income Statement
In the last 12 months, BioLineRx had revenue of 28.94M and earned -9.22M in profits. Earnings per share was -0.12.
| 28.94M |
| 19.68M |
| -20.41M |
| -9.22M |
| 3.92M |
| -147K |
| -0.12 |
Balance Sheet
The company has 10.44M in cash and 15.04M in debt, giving a net cash position of -4.6M.
| 10.44M |
| 15.04M |
| -4.6M |
| -399.83M |
| 38.91M |
| 11.7M |
Cash Flow
In the last 12 months, operating cash flow was -43.87M and capital expenditures -54K, giving a free cash flow of -43.93M.
| -43.87M |
| -54K |
| -43.93M |
| -0.04 |
Margins
Gross margin is 67.99%, with operating and profit margins of -70.52% and -31.86%.
| 67.99% |
| -70.52% |
| -31.86% |
| -31.86% |
| 13.54% |
| -70.52% |
| -151.79% |
Dividends & Yields
BLRX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for BLRX is $19, which is 266.8% higher than the current price. The consensus rating is "Buy".
| $19 |
| 266.8% |
| Buy |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jan 30, 2025. It was a backward split with a ratio of 1:40.
| Jan 30, 2025 |
| backward |
| 1:40 |
Scores
| -12.83 |
| 3 |